Drawing for ELTA MD

USPTO serial 87536488

ELTA MD

Reviewed by CopyMark Law Group

Reg. 5412066Status 702Registered
Filing date
Status date
Registration date
Feb 27, 2018
Examiner
STOIDES, KATHERINE
Law office
TMEG LAW OFFICE 101

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with ELTA MD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Melanie Jennison

Melanie Jennison Colgate-Palmolive Company300 Park AvenueColgate-Palmolive, Trademarks, PK-8New York, NY 10022

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated skin care preparationsACTIVEMar 1, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 29, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 29, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 29, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 29, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 29, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 29, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 10, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 10, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 10, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 10, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 10, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 25, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 25, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 25, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 25, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 20, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 20, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 20, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 17, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Feb 27, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 3, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 3, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 3, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jan 3, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 3, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 3, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 14, 2022ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 4, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 1, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 1, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 27, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 12, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 12, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 22, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 9, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 20, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Oct 20, 2017ALIEASSIGNED TO LIE—
Oct 20, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 20, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 20, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 19, 2017DOCKASSIGNED TO EXAMINER—
Jul 27, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 24, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance